Europe Noninvasive Fat Reduction Market
Europe Noninvasive Fat Reduction Market is growing at a CAGR of 15.2% to reach US$ 1,359.63 Million by 2031 from US$ 438.94 Million in 2023 by Technology, and End User.

Published On: Oct 2024

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Noninvasive Fat Reduction Market
Free Sample Buy Now
Europe Noninvasive Fat Reduction Market

At 15.2% CAGR, Europe Noninvasive Fat Reduction Market is Projected to be Worth US$ 1,359.63 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the Europe noninvasive fat reduction market was valued at US$ 438.94 million in 2023 and is anticipated to reach US$ 1,359.63 million by 2031, recording a CAGR of 15.2% from 2023 to 2031. Product approvals and innovations and rising demand for non-surgical fat reduction procedures are among the critical factors attributed to drive the Europe noninvasive fat reduction market growth.

The table below highlights the noninvasive fat reduction-centric products launched by companies operating in the market.

Date

Company Name

Product Name

Product Description

Jan-21

AbbVie, Inc.

CoolSculpting Elite

CoolSculpting Elite is a clinically proven technology to target,

freeze, and eliminate treated fat cells. The product is

FDA-cleared to treat visible fat bulges in nine areas of the body,

including the thigh, abdomen, and flank, as well as bra fat,

back fat, underneath the buttocks, upper arm, and the

submental and submandibular areas.

Apr-22

VLCC

VLCC Lipo-1060

VLCC Lipo-1060 treatment uses the latest laser appliances of

specific wavelengths that enable noninvasive body contouring

and slimming without pain and ensure that only fat cells are

eliminated with skin protection. The technology used in the

treatment has been clinically proven to consistently reduce the

fat contour in the abdomen and other areas of the body, with an

excellent safety profile in all skin types.

Mar-23

truBody Brand

-

truBody Brand is an award-winning treatment pair intended

for a customized, convenient, and complete approach to fat

reduction and muscle toning with only a 15-minute treatment

duration. The truSculpt (formerly truSculpt iD) for fat reduction

is a fast and effective combination approach, allowing

practitioners and patients to provide optimal results for reducing

fat and toning muscle. 

 

Additionally, Medicis’s Liposonix is a new treatment technique that uses a high-intensity focused ultrasound device to eliminate fat beneath the skin. The company reportedly received FDA approval for noninvasive waist circumference reduction. Such innovative product approvals and launches are expected to enhance the market growth of noninvasive fat reduction during the forecast period.

On the contrary, complications associated with noninvasive fat reduction procedures the growth of Europe noninvasive fat reduction market.

Based on technology, the Europe noninvasive fat reduction market is bifurcated into cryolipolysis, laser lipolysis, ultrasound, and others. The cryolipolysis segment held 55.2% market share in 2023, amassing US$ 242.48 million. It is projected to garner US$ 805.86 million by 2031 to register 16.2% CAGR during 2023–2031.

By end users, the Europe noninvasive fat reduction market is divided into hospitals, dermatology clinics & cosmetic clinics, and others. The dermatology clinics & cosmetic clinics segment held 74.5% share of Europe noninvasive fat reduction market in 2023, amassing US$ 326.97 million. It is projected to garner US$ 1,056.40 million by 2031 to expand at 15.8% CAGR from 2023 to 2031.

Based on country, the Europe noninvasive fat reduction market is categorized into the UK, Germany, France, Spain, Italy, and the Rest of Europe. Our regional analysis states that Germany captured 26.8% share of Europe noninvasive fat reduction market in 2023. It was assessed at US$ 118.00 million in 2023 and is likely to hit US$ 380.16 million by 2031, registering a CAGR of 15.7% during 2023–2031.

Key players operating in the Europe noninvasive fat reduction market are Cynosure LLC, Alma Lasers Ltd, Cutera Inc, Fotona, Sciton Inc, Lynton Lasers Ltd, Lumenis, Venus Concept Inc, and Candela Corporation, among others.

  • In August 2020, Lumenis announced launching of a new product "NuEra Tight" with Focal RF technology and this platform is a breakthrough in personalized noninvasive RF body treatments that meets patients unique needs. NuEra Tight with FocalRF technology is developed to provide tailor body treatments that meets patient's distinctive needs providing practitioners advanced tools for aesthetic patients accounting clinical indications and specific body areas all in one device.
  • In July 2020, Venus Concept Inc. received FDA 510(k) clearance to market and sell Venus Viva MD. Venus Viva MD is a noninvasive device intended to be used by aesthetic-related physicians/dermatologists. It expands the Company’s skin rejuvenation offerings beyond the Venus Viva and Venus Versa which were introduced to the medical aesthetics market in 2015 and 2016, respectively.

 

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com